Abstract | OBJECTIVE: To identify a potential therapeutic target for type 2 diabetes by comparing the subcutaneous interstitial fluid from type 2 diabetes patients and healthy men. METHODS: Proteomics was performed on the interstitial fluid of subcutaneous adipose tissue obtained by microdialysis from 7 type 2 diabetes patients and 8 healthy participants. 851 proteins were detected, of which 36 (including galectin-1) showed significantly altered expression in type 2 diabetes. We also measured galectin-1 expression in: (1) adipocytes isolated from adipose tissue biopsies from these participants; (2) subcutaneous adipose tissue of 24 obese participants before, during and after 16weeks on a very low calorie diet (VLCD); and (3) adipocytes isolated from 6 healthy young participants after 4weeks on a diet and lifestyle intervention to promote weight gain. We also determined the effect of galectin-1 on glucose uptake in human adipose tissue. RESULTS: CONCLUSION: Proteomics of the interstitial fluid in subcutaneous adipose tissue in vivo identified a novel adipokine, galectin-1, with a potential role in the pathophysiology of type 2 diabetes.
|
Authors | Emanuel Fryk, Jeanna Perman Sundelin, Lena Strindberg, Maria J Pereira, Massimo Federici, Nikolaus Marx, Fredrik H Nyström, Martin Schmelz, Per-Arne Svensson, Jan W Eriksson, Jan Borén, Per-Anders Jansson |
Journal | Metabolism: clinical and experimental
(Metabolism)
Vol. 65
Issue 7
Pg. 998-1006
(07 2016)
ISSN: 1532-8600 [Electronic] United States |
PMID | 27282870
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2016 Elsevier Inc. All rights reserved. |
Chemical References |
|
Topics |
- Adult
- Aged
- Diabetes Mellitus, Type 2
(metabolism)
- Extracellular Fluid
(chemistry)
- Galectin 1
(analysis)
- Humans
- Male
- Middle Aged
- Proteomics
|